As the science behind innovations in cell and gene treatments proliferates across more disease states and conditions, your path to commercialization must be scalable and customizable. 

As operations scale, there will be an increased emphasis on safeguarding these therapies through tight logistical timeframes, stringent temperature controls and more. In this webinar, join thought leaders from McKesson to learn how to address critical commercialization challenges – and the solutions – you may need to deliver on the promise of cell and gene therapies.

During the webinar, we will explore:

  • The challenges along the path to commercialization
  • Importance and value of dedication to the patient
  • How to craft the right commercialization strategy 
  • Why you need to support providers during the process